Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Glucagon-like peptide-1 receptor co-agonists for the treatment of metabolic disease
Enterococcus faecalis Enterococcus faecium Enterococcus spp
[9] To get Wegovy approved, you must meet all of: A 6-month weight-management program first documented behavioral modification, reduced-calorie diet, and increased physical activity with continuing follow-up (this is the real hurdle, not another drug) BMI 30 , or 27 with a weight-related condition (hypertension, type 2 diabetes, or dyslipidemia) Age 18+ (ages 1217 require the injection plus the comprehensive program) No drug step therapy: CVS Caremark's standard Wegovy policy does not require trying and failing another weight-loss drug first (some individual employer plans add it check yours) Wegovy also has separate coverage pathways for cardiovascular risk reduction (established heart disease + BMI 27, if you don't have type 2 diabetes) and MASH liver disease
In addition to lowering blood glucose levels to help treat type 2 diabetes, GLP-1 agonists also result in weight loss and other metabolic health benefits
Crohns Disease and Celiac Disease: These diseases cause inflammation and damage in the digestive tract, leading to poor absorption
US$ 26.86
US$ 22.84
US$ 26.68
US$ 24.49
